<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="an arthropod-borne alphavirus that causes hallmark debilitating polyarthralgia, fever, and" exact="rash" post="in patients. T cell-mediated immunity, especially CD4+ T cells,"/>
 <result pre="strategies that utilize their properties to provide adequate, lasting protection." exact="chikungunya" post="T cells immunopathology vaccination resident-memory T cells Funding Agency"/>
 <result pre="and the Americas (4, 12, 14, 15). CHIKV-infected patients develop" exact="chikungunya" post="fever (CHIKF), a febrile illness characterized with acute hallmark"/>
 <result pre="polyarthralgia, along with other disease manifestations like fever and maculopapular" exact="rash" post="(3, 16, 17). Symptoms usually manifest after 4–7 days"/>
 <result pre="in CD8+ T cells has been demonstrated to eliminate chronic" exact="malaria" post="infection in a mouse model (47), thus indicating that"/>
 <result pre="is no mouse model that develops the chronic arthralgia and" exact="arthritis" post="as seen in chronic patients. Thus, it remains to"/>
 <result pre="the spleens of mice that are co-infected with CHIKV and" exact="malaria" post="parasites (48). This event is due to the increased"/>
 <result pre="Med H. (1955) 49:33–57. 10.1016/0035-9203(55)90081-X 3.SchwartzOAlbertML. Biology and pathogenesis of" exact="chikungunya" post="virus. Nat Rev Microbiol. (2010) 8:491–500. 10.1038/nrmicro236820551973 4.StaplesEJBreimanRFPowersAM. Chikungunya"/>
 <result pre="10.1038/nrmicro236820551973 4.StaplesEJBreimanRFPowersAM. Chikungunya fever: an epidemiological review of a re-emerging" exact="infectious disease." post="Clin Infect Dis. (2009) 49:942–8. 10.1086/60549619663604 5.NimmannityaSHalsteadSCohenSMargiottaM. Dengue and"/>
 <result pre="disease. Clin Infect Dis. (2009) 49:942–8. 10.1086/60549619663604 5.NimmannityaSHalsteadSCohenSMargiottaM. Dengue and" exact="chikungunya" post="virus infection in man in Thailand, 1962–1964. I. observations"/>
 <result pre="Med Pub Health. (1997) 28:359–64. 9444021 7.PadbidriVGnaneswarT. Epidemiological investigations of" exact="chikungunya" post="epidemic at Barsi, Maharashtra state, India. J Hygiene Epidemiol"/>
 <result pre="M antibody in serum from patients following an outbreak of" exact="chikungunya" post="virus infection in Yangon, Myanmar. Trans R Soc Trop"/>
 <result pre="Trop Med Hygiene. (1992) 86:438–42. 10.1016/0035-9203(92)90260-J1332222 12.SergonKNjugunaCKalaniROfulaVOnyangoCKonongoiLSet al.. Seroprevalence of" exact="chikungunya" post="virus (CHIKV) infection on Lamu Island, Kenya, October 2004."/>
 <result pre="virus–vector interactions. Viruses. (2014) 6:4628–63. 10.3390/v611462825421891 14.PowersALogueC. Changing patterns of" exact="chikungunya" post="virus: re-emergence of a zoonotic arbovirus. J Gene Virol."/>
 <result pre="Assessing the origin of and potential for international spread of" exact="chikungunya" post="virus from the caribbean. PLoS Curr. (2014) 6, 1–15."/>
 <result pre="caribbean. PLoS Curr. (2014) 6, 1–15. 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da524944846 16.KamY-WOngEKRéniaLTongJ-CNgLF. Immuno-biology of" exact="chikungunya" post="and implications for disease intervention. Microbes Infect Institut Pasteur."/>
 <result pre="Institut Pasteur. (2009) 11:1186–96. 10.1016/j.micinf.2009.09.00319737625 17.WauquierNBecquartPNkogheDPadillaCNdjoyi-MbiguinoALeroyEM. The acute phase of" exact="chikungunya" post="virus infection in humans is associated with strong innate"/>
 <result pre="Dis. (2010) 204:115–23. 10.1093/infdis/jiq00621628665 18.ChowAHerZOngEKChenJDimatatacFKwekDJet al.. Persistent arthralgia induced by" exact="chikungunya" post="virus infection is associated with interleukin-6 and granulocyte macrophage"/>
 <result pre="J Infect Dis. (2011) 203:149–57. 10.1093/infdis/jiq04221288813 19.GardnerJAnrakuILeTTLarcherTMajorLRoquesPet al.. Chikungunya virus" exact="arthritis" post="in adult wild-type mice. J Virol. (2010) 84:8021–32. 10.1128/JVI.02603-0920519386"/>
 <result pre="Investig. (2010) 120:894–906. 10.1172/JCI4010420179353 21.SchilteCCoudercTChretienFSourisseauMGangneuxNGuivel-BenhassineFet al.. Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cells. J Exp"/>
 <result pre="Med. (2010) 207:429–42. 10.1084/jem.2009085120123960 22.LumFNgLF. Cellular and molecular mechanisms of" exact="chikungunya" post="pathogenesis. Antiviral Res. (2015) 120:165–74. 10.1016/j.antiviral.2015.06.00926092642 23.ChanY-HTeoTUttATanJJAmrunSBakarFet al.. Mutating"/>
 <result pre="chikungunya pathogenesis. Antiviral Res. (2015) 120:165–74. 10.1016/j.antiviral.2015.06.00926092642 23.ChanY-HTeoTUttATanJJAmrunSBakarFet al.. Mutating" exact="chikungunya" post="virus non-structural protein produces potent live-attenuated vaccine candidate. EMBO"/>
 <result pre="Early appearance of neutralizing immunoglobulin G3 antibodies is associated with" exact="chikungunya" post="virus clearance and long-term clinical protection. J Infect Dis."/>
 <result pre="(2012) 205:1147–54. 10.1093/infdis/jis03322389226 25.KamY-WLumFTeoTLeeWWSimarmataDHarjantoSet al.. Early neutralizing IgG response to" exact="chikungunya" post="virus in infected patients targets a dominant linear epitope"/>
 <result pre="26.KamY-WLeeWWSimarmataDHarjantoSTengT-STolouHet al.. Longitudinal analysis of the human antibody response to" exact="chikungunya" post="virus infection: implications for serodiagnosis and vaccine development. J"/>
 <result pre="10.1128/JVI.01780-1223015702 27.KamY-WLeeWWSimarmataDGrandRTolouHMeritsAet al.. Unique epitopes recognized by antibodies induced in" exact="chikungunya" post="virus-infected non-human primates: implications for the study of immunopathology"/>
 <result pre="28.LumFTeoTLeeWWKamY-WRéniaLNgLF. An essential role of antibodies in the control of" exact="chikungunya" post="virus infection. J Immunol. (2013) 190:6295–302. 10.4049/jimmunol.130030423670192 29.PooYNakayaHGardnerJLarcherTSchroderWALeTTet al.Diamond."/>
 <result pre="10.4049/jimmunol.130030423670192 29.PooYNakayaHGardnerJLarcherTSchroderWALeTTet al.Diamond. CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated" exact="chikungunya" post="virus arthritis. J Virol. (2014) 88:6862–72. 10.1128/JVI.03364-1324696480 30.PetitdemangeCWauquierNVieillardV. Control"/>
 <result pre="J Virol. (2014) 88:6862–72. 10.1128/JVI.03364-1324696480 30.PetitdemangeCWauquierNVieillardV. Control of immunopathology during" exact="chikungunya" post="virus infection. J Allergy Clin Immunol. (2015) 135:846–55. 10.1016/j.jaci.2015.01.03925843597"/>
 <result pre="31.TeoTLumFClaserCLullaVLullaAMeritsAet al.. A pathogenic role for CD4+ T cells during" exact="chikungunya" post="virus infection in mice. J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328"/>
 <result pre="J Immunol. (2013) 190:259–69. 10.4049/jimmunol.120217723209328 32.TeoTChanY-HLeeWWLumFAmrunSHerZet al.. Fingolimod treatment abrogates" exact="chikungunya" post="virus-induced arthralgia. Sci Transl Med. (2017) 9:eaal1333. 10.1126/scitranslmed.aal133328148838 33.de"/>
 <result pre="DiasCGoisBLimaVGuerra-GomesIAraújoJde GomesJet al.Human CD8 T-cell activation in acute and chronic" exact="chikungunya" post="infection. Immunology. (2018) 155:499–504. 10.1111/imm.1299230099739 34.HoarauJ-JBandjeeM-CTrototPDasTLi-Pat-YuenGDassaBet al.. Persistent chronic"/>
 <result pre="155:499–504. 10.1111/imm.1299230099739 34.HoarauJ-JBandjeeM-CTrototPDasTLi-Pat-YuenGDassaBet al.. Persistent chronic inflammation and infection by" exact="chikungunya" post="arthritogenic alphavirus in spite of a robust host immune"/>
 <result pre="10.4049/jimmunol.090025520404278 35.PratheekBSuryawanshiARChattopadhyaySChattopadhyayS. In silico analysis of MHC-I restricted epitopes of" exact="chikungunya" post="virus proteins: implication in understanding anti-CHIKV CD8+ T cell"/>
 <result pre="promiscuous T cell epitopes in RNA dependent RNA polymerase of" exact="chikungunya" post="virus. Asian Pacific J Trop Med. (2017) 10:760–4. 10.1016/j.apjtm.2017.07.02328942824"/>
 <result pre="37.LorenteEBarrigaAGarcía-ArriazaJLemonnierFAEstebanMLópezD. Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from" exact="chikungunya" post="6K protein. PLoS Negl Trop Dis. (2017) 11:e0006036. 10.1371/journal.pntd.000603629084215"/>
 <result pre="Immunol. (2015) 194:678–89. 10.4049/jimmunol.140183325488988 39.BrookeCBDemingDJWhitmoreACWhiteLJJohnstonRE. T cells facilitate recovery from" exact="venezuelan equine encephalitis" post="virus-induced encephalomyelitis in the absence of antibody. J Virol."/>
 <result pre="194:678–89. 10.4049/jimmunol.140183325488988 39.BrookeCBDemingDJWhitmoreACWhiteLJJohnstonRE. T cells facilitate recovery from venezuelan equine" exact="encephalitis" post="virus-induced encephalomyelitis in the absence of antibody. J Virol."/>
 <result pre="39.BrookeCBDemingDJWhitmoreACWhiteLJJohnstonRE. T cells facilitate recovery from venezuelan equine encephalitis virus-induced" exact="encephalomyelitis" post="in the absence of antibody. J Virol. (2010) 84:4556–68."/>
 <result pre="84:4556–68. 10.1128/JVI.02545-0920181704 40.HawmanDWStoermerKAMontgomerySAPalPOkoLDiamondMSet al.. Chronic joint disease caused by persistent" exact="chikungunya" post="virus infection is controlled by the adaptive immune response."/>
 <result pre="malaria. Sci Rep. (2016) 6:26210. 10.1038/srep2621027217330 48.TeoTHowlandSWClaserCGunSPohCLeeWWet al.. Co-infection with" exact="chikungunya" post="virus alters trafficking of pathogenic CD8+ T cells into"/>
 <result pre="al.. Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls" exact="chikungunya" post="virus arthritis. Sci Transl Med. (2017) 9:eaah3438. 10.1126/scitranslmed.aah343828148840 50.CarissimoGTeoTChanY-HLeeCLeeBTorres-RuestaAet"/>
 <result pre="Sci Transl Med. (2017) 9:eaah3438. 10.1126/scitranslmed.aah343828148840 50.CarissimoGTeoTChanY-HLeeCLeeBTorres-RuestaAet al.. Viperin controls" exact="chikungunya" post="virus–specific pathogenic T cell IFNγ Th1 stimulation in mice."/>
 <result pre="(2010) 84:10877–87. 10.1128/JVI.00949-1020686047 52.LeeWWTeoTHerZLumFKamY-WHaaseDet al.. Expanding regulatory T cells alleviates" exact="chikungunya" post="virus-induced pathology in mice. J Virol. (2015) 89:7893–904. 10.1128/JVI.00998-1525995249"/>
 <result pre="10.1128/JVI.00998-1525995249 53.KulkarniSGanuMJayawantPThanapatiSGanuATripathyA. Regulatory T cells and IL-10 as modulators of" exact="chikungunya" post="disease outcome: a preliminary study. Eur J Clin Microbiol"/>
 <result pre="of NK and NKT-like populations during the early stages of" exact="chikungunya" post="infection. Front Microbiol. (2015) 6:23. 10.3389/fmicb.2015.0089525699024 55.ThanapatiSGanuMATripathyAS. Differential inhibitory"/>
 <result pre="59.LongKMFerrisMTWhitmoreACMontgomerySAThurlowLRMcGeeCEet al.. γδ T cells play a protective role in" exact="chikungunya" post="virus-induced disease. J Virol. (2016) 90:433–43. 10.1128/JVI.02159-1526491151 60.HallengärdDLumFKümmererBMLullaALullaVGarcía-ArriazaJet al.."/>
 <result pre="Virol. (2016) 90:433–43. 10.1128/JVI.02159-1526491151 60.HallengärdDLumFKümmererBMLullaALullaVGarcía-ArriazaJet al.. Prime-boost immunization strategies against" exact="chikungunya" post="virus. J Virol. (2014) 88:13333–43. 10.1128/JVI.01926-1425210177 61.Weger-LucarelliJChuHAliotaMTPartidosCDOsorioJE. A novel"/>
 <result pre="J Virol. (2014) 88:13333–43. 10.1128/JVI.01926-1425210177 61.Weger-LucarelliJChuHAliotaMTPartidosCDOsorioJE. A novel MVA vectored" exact="chikungunya" post="virus vaccine elicits protective immunity in mice. PLoS Negl"/>
 <result pre="Negl Trop Dis. (2014) 8:e2970. 10.1371/journal.pntd.000297025058320 62.ArévaloMTHuangYJonesCARossTM. Vaccination with a" exact="chikungunya" post="virus-like particle vaccine exacerbates disease in aged mice. PLoS"/>
 <result pre="10.1371/journal.pntd.000731631026260 63.ReisingerECTschismarovRBeublerEWiedermannUFirbasCLoebermannMet al.. Immunogenicity, safety, and tolerability of the measles-vectored" exact="chikungunya" post="virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled"/>
 <result pre="392:2718–27. 10.1016/S0140-6736(18)32488-730409443 64.ChuaC-LSamI-CMeritsAChanY-F. Antigenic variation of East/Central/South African and Asian" exact="chikungunya" post="virus genotypes in neutralization by immune sera. PLoS Negl"/>
 <result pre="Negl Trop Dis. (2016) 10:e0004960. 10.1371/journal.pntd.000496027571254 65.GorchakovRWangELealGForresterNLPlanteKRossiSLet al.. Attenuation of" exact="chikungunya" post="virus vaccine strain 181/clone 25 is determined by two"/>
 <result pre="69.LiZ-RZarnitsynaVILowenACWeissmanDKoelleKKohlmeierJEet al.. Why are CD8 T cell epitopes of human" exact="influenza" post="a virus conserved?J Virol. (2019) 93:e01534-18. 10.1128/JVI.01534-1830626684 70.ShinHIwasakiA. Tissue-resident"/>
 <result pre="USA. (2012) 109:16534–9. 10.1073/pnas.121041810923010928 89.MaletHCoutardBJamalSDutartreHPapageorgiouNNeuvonenMet al.. The crystal structures of" exact="chikungunya" post="and venezuelan equine encephalitis virus nsP3 macro domains define"/>
 <result pre="109:16534–9. 10.1073/pnas.121041810923010928 89.MaletHCoutardBJamalSDutartreHPapageorgiouNNeuvonenMet al.. The crystal structures of chikungunya and" exact="venezuelan equine encephalitis" post="virus nsP3 macro domains define a conserved adenosine binding"/>
 <result pre="89.MaletHCoutardBJamalSDutartreHPapageorgiouNNeuvonenMet al.. The crystal structures of chikungunya and venezuelan equine" exact="encephalitis" post="virus nsP3 macro domains define a conserved adenosine binding"/>
 <result pre="10.1128/JVI.75.21.10118-10131.200111581380 92.TanYLamTHeberlein-LarsonLASmoleSCAugusteAJHenniganSet al.. Large-scale complete-genome sequencing and phylodynamic analysis of" exact="eastern equine encephalitis" post="virus reveals source-sink transmission dynamics in the United States."/>
 <result pre="al.. Large-scale complete-genome sequencing and phylodynamic analysis of eastern equine" exact="encephalitis" post="virus reveals source-sink transmission dynamics in the United States."/>
</results>
